These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 20662474)

  • 21. [Oxidative stress and its effects on insulin resistance and pancreatic beta-cells dysfunction: relationship with type 2 diabetes mellitus complications].
    Lopes JP; Oliveira SM; Soares Fortunato J
    Acta Med Port; 2008; 21(3):293-302. PubMed ID: 18674421
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Understanding the pathogenesis and treatment of insulin resistance and type 2 diabetes mellitus: what can we learn from transgenic and knockout mice?
    Mauvais-Jarvis F; Kahn CR
    Diabetes Metab; 2000 Dec; 26(6):433-48. PubMed ID: 11173714
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Hypertension, microalbuminuria and insulin resistance in diabetes mellitus].
    Bretzel RG
    Wien Klin Wochenschr; 1994; 106(24):774-92. PubMed ID: 7846897
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The inflammatory consequences of psychologic stress: relationship to insulin resistance, obesity, atherosclerosis and diabetes mellitus, type II.
    Black PH
    Med Hypotheses; 2006; 67(4):879-91. PubMed ID: 16781084
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recent advances in the relationship between obesity, inflammation, and insulin resistance.
    Bastard JP; Maachi M; Lagathu C; Kim MJ; Caron M; Vidal H; Capeau J; Feve B
    Eur Cytokine Netw; 2006 Mar; 17(1):4-12. PubMed ID: 16613757
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanisms linking obesity to insulin resistance and type 2 diabetes.
    Kahn SE; Hull RL; Utzschneider KM
    Nature; 2006 Dec; 444(7121):840-6. PubMed ID: 17167471
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of grape seed extract in Type 2 diabetic subjects at high cardiovascular risk: a double blind randomized placebo controlled trial examining metabolic markers, vascular tone, inflammation, oxidative stress and insulin sensitivity.
    Kar P; Laight D; Rooprai HK; Shaw KM; Cummings M
    Diabet Med; 2009 May; 26(5):526-31. PubMed ID: 19646193
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antioxidant drugs for treating beta-cell oxidative stress in type 2 diabetes: glucose-centric versus insulin-centric therapy.
    Robertson RP
    Discov Med; 2010 Feb; 9(45):132-7. PubMed ID: 20193639
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inflammatory markers, insulin resistance and carotid intima-media thickness in North-Indian type 2 diabetic subjects.
    Ahmad J; Ahmned F; Siddiqui MA; Khan AR; Katyal P; Hameed B; Ahmad I
    J Assoc Physicians India; 2007 Oct; 55():693-9. PubMed ID: 18173021
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypoglycemic pharmacological treatment of type 2 diabetes: targeting the endothelium.
    Nathanson D; Nyström T
    Mol Cell Endocrinol; 2009 Jan; 297(1-2):112-26. PubMed ID: 19038307
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevention of type 2 diabetes mellitus from the viewpoint of genetics.
    Park KS
    Diabetes Res Clin Pract; 2004 Dec; 66 Suppl 1():S33-5. PubMed ID: 15563977
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pancreatic islet inflammation in type 2 diabetes: from alpha and beta cell compensation to dysfunction.
    Ehses JA; Ellingsgaard H; Böni-Schnetzler M; Donath MY
    Arch Physiol Biochem; 2009 Oct; 115(4):240-7. PubMed ID: 19645635
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapy for type 2 diabetes mellitus.
    Elson DF; Meredith M
    WMJ; 1998 Mar; 97(3):49-54. PubMed ID: 9540451
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pathophysiology of obesity-induced insulin resistance and type 2 diabetes mellitus.
    Tataranni PA
    Eur Rev Med Pharmacol Sci; 2002; 6(2-3):27-32. PubMed ID: 12708607
    [No Abstract]   [Full Text] [Related]  

  • 35. [The metabolic syndrome. Pathophysiologic causes, diagnosis, therapy].
    Rett K; Wicklmayr M; Standl E
    Wien Klin Wochenschr; 1994; 106(24):750-7. PubMed ID: 7846893
    [TBL] [Abstract][Full Text] [Related]  

  • 36. C-reactive protein, its role in inflammation, Type 2 diabetes and cardiovascular disease, and the effects of insulin-sensitizing treatment with thiazolidinediones.
    Nesto R
    Diabet Med; 2004 Aug; 21(8):810-7. PubMed ID: 15270782
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of green tea consumption on inflammation, insulin resistance and pulse wave velocity in type 2 diabetes patients.
    Ryu OH; Lee J; Lee KW; Kim HY; Seo JA; Kim SG; Kim NH; Baik SH; Choi DS; Choi KM
    Diabetes Res Clin Pract; 2006 Mar; 71(3):356-8. PubMed ID: 16169629
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exercise maintains euglycemia in association with decreased activation of c-Jun NH2-terminal kinase and serine phosphorylation of IRS-1 in the liver of ZDF rats.
    Király MA; Campbell J; Park E; Bates HE; Yue JT; Rao V; Matthews SG; Bikopoulos G; Rozakis-Adcock M; Giacca A; Vranic M; Riddell MC
    Am J Physiol Endocrinol Metab; 2010 Mar; 298(3):E671-82. PubMed ID: 19996384
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An integrated medical treatment for type-2 diabetes.
    Bocci V; Zanardi I; Huijberts MS; Travagli V
    Diabetes Metab Syndr; 2014; 8(1):57-61. PubMed ID: 24661761
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Exercise and oxidative stress in type 2 diabetes mellitus].
    Poblete-Aro C; Russell-Guzmán J; Parra P; Soto-Muñoz M; Villegas-González B; Cofré-Bolados C; Herrera-Valenzuela T
    Rev Med Chil; 2018 Mar; 146(3):362-372. PubMed ID: 29999107
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.